A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.
New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn\u2019s disease - paving the way for targeted treatments.
RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
From 29 September to 1 October 2025, researchers from across the world gathered in Oxford for a unique conference and hackathon exploring how advances in artificial intelligence can deepen understanding of T-cell biology.
Professor Ellie Tzima from the Radcliffe Department of Medicine has joined an international team of scientists awarded an $8.5 million grant from the Leducq Foundation to study Peripheral Artery Disease (PAD) and accelerate the development of new therapies.
The University of Oxford has announced a gift of \u00a310 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes (T1D). This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.
Oxford scientists build a connected, \u2018multi-organoid\u2019 platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
Congratulations to Dr Christos Kotanidis, NIHR-funded Academic Clinical Lecturer in Cardiology, who has been awarded the 2025 ESC Young Investigator Award in Preventive Cardiology at the European Society of Cardiology Congress in Madrid.
A clinical trial led by researchers in the University of Oxford\u2019s Radcliffe Department of Medicine and Oxford Population Health, has found that while a structured weight-loss programme helped older adults with atrial fibrillation (AF) shed weight safely and sustainably, it did not improve their heart rhythm symptoms or reduce the need for further treatment.
On 28 August, RDM signed a Memorandum of Understanding with the National Defense Medical University and Tri-Service General Hospital in Taiwan which will provide funding for their students who have successfully enrolled on the DPhil in Medical Sciences.
Earlier this year, a group of researchers from the MRC Weatherall Institute of Molecular Medicine attended the Big Bang Fair in Birmingham, showcasing medical research through a series of hands-on activities.
A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut f\u00fcr Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.
Study led by Psaila Group uncovers previously unknown function of platelets as DNA \u2018vacuum cleaners\u2019 in the blood, with profound implications for cancer diagnosis and prenatal screening.
![\"Patient](\"https://www.rdm.ox.ac.uk/news/drug-resistance-targeted-aml-therapy/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n